.png)
SPARK: Conversations by Children's Healthcare Canada
At the crossroads of children’s healthcare, system improvement, and leadership, this solutions-focused, interview-style podcast brings you engaging stories, reflections, and system improvement ideas from leaders in Canadian children’s healthcare.
Enjoyed the episode? Leave us a rating or review, share with your colleagues, and be sure to subscribe!
SPARK: Conversations by Children's Healthcare Canada
The COVID-19 Vaccine and Canada's Children and Youth
COVID vaccines have been approved in Canada for youth and adults 12 and older. The National Advisory Committee on Immunization (NACI, 2021) recommends that (with very few exceptions) that a complete series with a Pfizer-BioNTech COVID-19 vaccine should be offered to individuals 12 to 18 years of age. While Pfizer recently announced a COVID vaccine trial involving children aged 6 months to 11 years, most children younger than 12 are not likely to be vaccinated in Canada until late winter or early spring 2022 (Dailey, 2021; Global News, 2021). Studies are underway to develop and test vaccines for those younger children.
We will hear from our guest, Dr. Jim Kellner, about the status of, prioritization of, and plan for the delivery of safe and effective COVID vaccines to children of all ages.